LAURA THOMPSON: Open Payments
NPI 1063147833 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 27 payments from 10 companies in 2025. Trend: 2023 $564 · 2024 $476 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 5 | $124 |
| AstraZeneca Pharmaceuticals LP | 5 | $97 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $95 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| GENZYME CORPORATION | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Grifols USA, LLC | 1 | $24 |
| Amgen Inc. | 1 | $15 |
Products named: Hizentra, NEFFY, DUPIXENT, TRELEGY ELLIPTA, TEZSPIRE, AIRSUPRA, Xembify, EOHILIA.
Industry payments across VA — which companies pay providers there.
